Gully Bop expects big Caymanas crowd

Gully Bop on Wednesday said he was expecting “likkle more” than the 7,500-strong crowd that turned out for Sting 2014, as he prepares to headline tomorrow’s McKay Security Caymanas Live Entertainment Series at Caymanas Park.

“From mi born, mi neva guh ova deh. Mi don’t know weh in deh look like. Mi neva guh Caymanas Park yet, but mi duh Sting ah Portmore, an mi expect likkle more people than Sting,” the overnight dancehall sensation told THE WEEKEND STAR.

A Sting-like crowd at the Portmore racetrack would swell Caymanas Park’s Saturday attendance by more than 50 per cent. The racetrack attracts an average crowd of 5,000 for Saturday racemeets.

“Caymanas thing nuh so expensive like Sting. Dat almost free, and Gully Bop a deh deh. From Gully Bop deh deh, dat a guh sell off, straight up,” the new dancehall star added.

Gully Bop joins a select group of artistes to grace the McKay Security Caymanas Live Series, which started with Busy Signal. Other top acts to have appeared on the series included I-Octane, Spice, Tifa, Kalado and Alkaline.

Though he shot to stardom last November, a month before headlining Sting 2014, Gully Bop is a 50-year-old veteran formerly known as Countryman.

Father

Father of three children, now adults – 27 and 25-year-old girls, and a 22-year-old son – Gully Bop said he has done his homework on Caymanas Park, which regards itself as offering “family entertainment”.

“Let me explain this thing. I am a very intelligent deejay; those songs you hear playing, don’t expect to hear that out of my mouth at Caymanas Park. I don’t deejay those things at VIP events. It’s a different crowd. You have to know how you are going to talk. A nuh Sting thing. All the prime minister could be in the crowd. You have to be very careful,” he said.

View the original article here

Gully Bop expects big Caymanas crowd

Gully Bop expects big Caymanas crowd

Gully Bop on Wednesday said he was expecting “likkle more” than the 7,500-strong crowd that turned out for Sting 2014, as he prepares to headline tomorrow’s McKay Security Caymanas Live Entertainment Series at Caymanas Park.

“From mi born, mi neva guh ova deh. Mi don’t know weh in deh look like. Mi neva guh Caymanas Park yet, but mi duh Sting ah Portmore, an mi expect likkle more people than Sting,” the overnight dancehall sensation told THE WEEKEND STAR.

A Sting-like crowd at the Portmore racetrack would swell Caymanas Park’s Saturday attendance by more than 50 per cent. The racetrack attracts an average crowd of 5,000 for Saturday racemeets.

“Caymanas thing nuh so expensive like Sting. Dat almost free, and Gully Bop a deh deh. From Gully Bop deh deh, dat a guh sell off, straight up,” the new dancehall star added.

Gully Bop joins a select group of artistes to grace the McKay Security Caymanas Live Series, which started with Busy Signal. Other top acts to have appeared on the series included I-Octane, Spice, Tifa, Kalado and Alkaline.

Though he shot to stardom last November, a month before headlining Sting 2014, Gully Bop is a 50-year-old veteran formerly known as Countryman.

Father

Father of three children, now adults – 27 and 25-year-old girls, and a 22-year-old son – Gully Bop said he has done his homework on Caymanas Park, which regards itself as offering “family entertainment”.

“Let me explain this thing. I am a very intelligent deejay; those songs you hear playing, don’t expect to hear that out of my mouth at Caymanas Park. I don’t deejay those things at VIP events. It’s a different crowd. You have to know how you are going to talk. A nuh Sting thing. All the prime minister could be in the crowd. You have to be very careful,” he said.

View the original article here

Gully Bop expects big Caymanas crowd

Tourism Minister expects boost in cruise sector next month

Tourism Minister Dr Wykeham McNeil has declared that Jamaica’s cruise sector will receive a significant boost next month, with Thomson Dream home porting one ot its vessels in Montego Bay. 

Thomson Dream, which is the cruise arm of  European travel and tourism company (TUI) made the announcement last year that it intends to base one of its cruise ships in Jamaica.     The home porting of the ship in Montego Bay will result in an additional four flights out of Europe each week, bringing passengers for the vessel.Dr McNeil says an estimated 30 per cent of  the passengers who come for the cruise ships are expected to stay at alocal  hotel.  The Tourism Minister also announced on Wednesday that the country welcomed 939,000 cruise passengers during the months, January to August. That was up 10 per cent from a year ago.  

Falmouth, which handles 700,000 passengers annually, is the biggest port of call in Jamaica, followed by Ocho Rios and Montego Bay.   

View the original article here

Tourism Minister expects boost in cruise sector next month

IMF still expects 1.4% expansion

The International Monetary Fund (IMF) says it still expects the Jamaican economy to expand at a rate of 1.4 percent this year.

The latest outlook came from IMF Representative to Jamaica, Bert van Selm, as the entity revised its forecast for global growth.   

On Thursday the IMF said, it expects global growth to be 3.4 percent this year, which is down from the 3.7 percent it forecast in April. 

Growth for the region has also been revised downwards to 2 percent from 2 .5 percent.

View the original article here

IMF still expects 1.4% expansion

IMF still expects 1.4% expansion

The International Monetary Fund (IMF) says it still expects the Jamaican economy to expand at a rate of 1.4 percent this year.

The latest outlook came from IMF Representative to Jamaica, Bert van Selm, as the entity revised its forecast for global growth.   

On Thursday the IMF said, it expects global growth to be 3.4 percent this year, which is down from the 3.7 percent it forecast in April. 

Growth for the region has also been revised downwards to 2 percent from 2 .5 percent.

View the original article here

IMF still expects 1.4% expansion

Lasco expects Pfizer face-off in high court by March

LASCO Distributors Limited (LDL) revealed that by next March it will battle pharmaceutical giant Pfizer in the UKbased Privy Council, in order to secure the $400 million in damages awarded to the company in the lower courts.

The amount represents the distribution company’s expected compensation for lost earnings over some seven years in which the sale of blood pressure drug Las Amlodipine was halted by a 2005 injunction issued to Pfizer, which had claimed that Lasco and Medimpex Jamaica used its patent-protected drug, Salts of Amlodipine, in their product.The Supreme Court ruled in favour of Lasco and Medimpex in 2009, and the Court of Appeal dismissed Pfizer’s objections in June last year.Pfizer is appealing the decision at the island’s highest court — the Privy Council.“It is anticipated that the matter should come before the Privy Council either by the end of this year or during the first quarter of next year,” indicated LDL in notes accompanying its annual report released this week to the Jamaica Stock Exchange (JSE).LDL reported year-end net profit of $506.8 million on $8.2 billion in revenues. The award, if maintained, would increase Lasco’s equity base by some 20 per cent from the $1.8 billion reported at its March 2013 year-end.“The attorneys are of the opinion that the company should be successful on this appeal and anticipate that the amount to be recovered by the company may be approximately $400 million,” stated LDL’s 2012 annual report.Jamaica Money Market Brokers, in a July 2013 market research, indicated that the payout could grow to $1billion from Pfizer: “The company stands to improve its results through the distribution of new products (baby formulas, pharmaceutical pills, juices, water, etc) into new markets and Jamaica. The company also stands to benefit from a lawsuit settlement of $1 billion from Pfizer. Following the ruling in the court of appeal, if successful, the company will pay a special dividend to shareholders and use the remainder to improve the overall operations of the company.”A loss at the Privy Council would cost Lasco $25 million plus damages arising from profiting of the sale, stated the LDL annual report.According to records submitted in court, total sales of Medimpex’s product, Normodipine, amounted to approximately $45.2 million between 2001 and 2005, while Lasco’s drug, Las Amlodipine, brought in $24.3 million in revenue between May 2002 and December 2005.Pfizer reportedly sold US$1.2 million of its own product, Norvasc, in Jamaica in 2001, but its revenue fell to US$481,000 in 2002 when the two local companies introduced their hypertension and heart treatment drugs. The exterior of Pfizer in Groton, Connecticut. (PHOTO: AP)

View the original article here

Lasco expects Pfizer face-off in high court by March

U15 High Performance camp coach expects intense development

View the original article here

U15 High Performance camp coach expects intense development